RA
ITCI
Royce & Associates’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-37,500
| Closed | -$3.13M | – | 876 |
|
|
2024
Q4 | $3.13M | Hold |
37,500
| – | – | 0.03% | 558 |
|
|
2024
Q3 | $2.74M | Hold |
37,500
| – | – | 0.02% | 579 |
|
|
2024
Q2 | $2.57M | Buy |
37,500
+15,000
| +67% | +$1.03M | 0.02% | 588 |
|
|
2024
Q1 | $1.56M | Buy |
+22,500
| New | +$1.56M | 0.01% | 665 |
|
|
2018
Q2 | – | Sell |
-30,000
| Closed | -$632K | – | 1264 |
|
|
2018
Q1 | $632K | Hold |
30,000
| – | – | ﹤0.01% | 1028 |
|
|
2017
Q4 | $434K | Hold |
30,000
| – | – | ﹤0.01% | 1050 |
|
|
2017
Q3 | $473K | Hold |
30,000
| – | – | ﹤0.01% | 1027 |
|
|
2017
Q2 | $373K | Hold |
30,000
| – | – | ﹤0.01% | 1052 |
|
|
2017
Q1 | $488K | Hold |
30,000
| – | – | ﹤0.01% | 1043 |
|
|
2016
Q4 | $453K | Buy |
30,000
+22,300
| +290% | +$337K | ﹤0.01% | 1015 |
|
|
2016
Q3 | $117K | Hold |
7,700
| – | – | ﹤0.01% | 1060 |
|
|
2016
Q2 | $299K | Buy |
+7,700
| New | +$299K | ﹤0.01% | 1027 |
|